医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
N-乙酰基-2'-O-甲基胞苷 | N<sup>4</sup>-acetyl-2'-O-methyl cytidine | 113886-71-8 | C12H17N3O6 |
|
N-乙酰基-1,6-二氨基吡啶 | N-(6-aminopyridin-2-yl)acetamide | 1075-62-3 | C7H9N3O |
|
N-乙酰-D-苯丙氨酸 | (R)-N-acetylphenylalanin | 10172-89-1 | C11H13NO3 |
|
N-乙烯基咔唑 | 9-vinyl-9H-carbazole | 1484-13-5 | C14H11N |
|
N-乙氧羰基高哌嗪 | 1-ethoxycarbonyl-1,4-diazacycloheptane | 18739-39-4 | C8H16N2O2 |
|
N-乙基羟胺盐酸盐 | N-ethylhydroxylamine hydrochloride | 42548-78-7 | C2H8NO*Cl |
|
N-乙基碘化喹醛啶 | 1-ethyl-2-methylquinolinium iodide | 606-55-3 | C12H14N*I |
|
N-乙基哌嗪 | 4-ethylpiperazine | 5308-25-8 | C6H14N2 |
|
N-乙基吡啶-3-胺 | N-ethylpyridin-3-amine | 32405-70-2 | C7H10N2 |
|
N-乙基双氧哌嗪酰氨苯乙酸 | (R)-2-<(4-ethyl-2,3-dioxopiperazin-1-yl)carbonylamino>-2-phenylacetic acid | 63422-71-9 | C15H17N3O5 |
|
N-乙基-N’-[2-甲氧基-4-[5-甲基-4-[[(1S)-1-(3-吡啶基)丁基]氨基]-2-嘧啶基]苯基]脲 | lexibulin | 917111-44-5 | C24H30N6O2 |
|
N-乙基-N-3-((3-二甲氨基-1-氧代-2-丙烯基)苯基)乙酰胺 | N-{3-[3-(dimethylamino)prop-2-enoyl]phenyl}-N-ethylacetamide | 96605-66-2 | C15H20N2O2 |
|
N-乙基-N-(4-吡啶甲基)阿托胺 | Apotropicamid | 57322-50-6 | C17H18N2O |
|
N-乙基-5-氟-2-嘧啶胺 | N-Ethyl-5-fluoropyrimidin-2-amine | 1289386-10-2 | C6H8FN3 |
|
N-乙基-4-羟基哌啶 | 1-ethylpiperidin-4-ol | 3518-83-0 | C7H15NO |
|
N-乙基-4-吡啶胺 | 4-(ethylamino)pyridine | 35036-85-2 | C7H10N2 |
|
N-乙基-4-吡啶羧酰胺 | N-ethyl-4-pyridinecarboxamide | 41116-48-7 | C8H10N2O |
|
N-乙基-3-羟基哌啶 | 1-ethyl-3-hydroxypiperidine | 13444-24-1 | C7H15NO |
|
N-乙基-3-氰基-4-甲基-6-羟基-2-吡啶酮 | 1-ethyl-2-hydroxy-4-methyl-6-oxopyridine-3-carboxamide | 29097-12-9 | C9H12N2O3 |
|
N-乙基-3-吡啶甲胺 | N-ethyl-N-(3-pyridylmethyl)amine | 3000-75-7 | C8H12N2 |
|
N-乙基-2-甲基吲哚 | 1-ethyl-2-methylindole | 40876-94-6 | C11H13N |
|
N-乙基-2-吡啶甲胺 | N-(pyridin-2-ylmethyl)ethanamine | 51639-58-8 | C8H12N2 |
|
N-丙基-5-溴吡啶甲酰胺 | 5-Bromo-N-propylpicolinamide | 845305-89-7 | C9H11BrN2O |
|
N-丁基-N-乙基-2,5,6-三甲基-7-(2,4,6-三甲基苯基)-7H-吡咯并[2,3-d]嘧啶-4-胺单盐酸盐 | Antalarmin hydrochloride | 220953-69-5 | C24H35ClN4 |
|
N-丁基-3-氰基-4-甲基-6-羟基-2-吡啶酮 | 1-butyl-2-hydroxy-4-methyl-6-oxopyridine-3-carbonitrile | 39108-47-9 | C11H14N2O2 |
|
N-{[(1S,2S,10R,12S,13S)-12,18-二羟基-7,17-二甲氧基-6,16,21-三甲基-5,8-二氧代-11,21-二氮杂五环[11.7.1.02,11.04,9.015,20]二十一-4(9),6,15,17,19-五烯-10-基]甲基}-L-丙氨酰胺 | safracin B | 87578-99-2 | C28H36N4O7 |
|
N-boc哌啶-4-烯基溴化物 | tert-butyl 4-bromo-5,6-dihydropyridine-1(2H)-carboxylate | 159503-91-0 | C10H16BrNO2 |
|
N-boc-7-溴-3,4-二氢-2H-苯并[1,4]噁嗪 | tert-butyl 7-bromo-3,4-dihydro-2H-1,4-benzoxazine-4-carboxylate | 1220039-59-7 | C13H16BrNO3 |
|
N-boc-5-溴-2-嘧啶甲胺 | tert-butyl N-[(5-bromopyrimidin-2-yl)methyl]carbamate | 1235451-38-3 | C10H14BrN3O2 |
|
N-boc-4,4-联哌啶 | 1-tert-butoxycarbonyl-4,4'-bipiperidine | 171049-35-7 | C15H28N2O2 |
|
N-boc-1H-吲哚-5-甲醛 | tert-butyl 5-formyl-1H-indole-1-carboxylate | 279256-09-6 | C14H15NO3 |
|
N-boc-1,2,3,6-四氢吡啶-4-羧酸 | 1-(tert-butoxycarbonyl)-1,2,3,6-tetrahydropyridine-4-carboxylic acid | 70684-84-3 | C11H17NO4 |
|
N-[(ε-苄氧基羰基氨基)己酰基]-β-L-呋喃核糖胺 | N-[(epsilon-Benzyloxycarbonylamino)caproyl]-beta-L-fucopyranosylamine | 35978-96-2 | C20H30N2O7 |
|
N-[苯胺基(苯氧基)磷酰基]苯胺 | phenyl dianilidophosphate | 18995-02-3 | C18H17N2O2P |
|
N-[芴甲氧羰基]-4-[[[(4S)-六氢-2,6-二氧代-4-嘧啶基]羰基]氨基]-L-苯丙氨酸 | Fmoc-Aph(Hor)-OH | 1253282-31-3 | C29H26N4O7 |
|
N-[[2-[[[4-(氨基亚氨基甲基)苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-n-(2-吡啶)-beta-丙氨酸乙酯盐酸盐 | ethyl 3-(2((4-carbamimidoylphenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride | 211914-50-0 | C27H29N7O3*ClH |
|
N-[[2-(氯甲基)-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基-beta-丙氨酸乙酯 | N-[[2-(chloromethyl)-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridyl-β-alanine ethyl ester | 1307233-94-8 | C20H21ClN4O3 |
|
N-[5-[(4-甲基苯基)磺酰基]-5H-吡咯并[2,3-B]吡嗪-2-基]氨基甲酸乙酯 | ethyl (5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)carbamate | 1869118-24-0 | C16H16N4O4S |
|
N-[5-(联苯-膦酰基甲基)-4-(4-氟-苯基)-6-异丙基-嘧啶-2-基]-N-甲基-甲烷磺胺 | N-(5-((diphenylphosphoryl)methyl)-4-(4-fluorophenyl)- 6-isopropylpyrimidin-2-yl)-N-methylmethansulfonamide | 289042-10-0 | C28H29FN3O3PS |
|
N-[5-(三氟甲基)-2-吡啶基]-N-甲基肼 | N-methyl-N-(5-trifluoromethyl-pyridin-2-yl)-hydrazine | 163620-24-4 | C7H8F3N3 |
|
N-[5-(4-溴苯基)-6-氯-4-嘧啶基]-N'-丙基氨基磺酰胺 | N-5-(4-bromophenyl)-6-chloro-4-pyrimidinyl-N'-propylsulfamide | 1393813-42-7 | C13H14BrClN4O2S |
|
N-[4-溴-2-(2-吡啶甲酰基)苯基]-2-氯乙酰胺 | N-(4-bromo-2-picolinoylphenyl)-2-chloroacetamide | 41526-21-0 | C14H10BrClN2O2 |
|
N-[4-三氟甲基嘧啶-2-基]乙二胺 | tert-butyl furan-2-ylcarbamate | 56267-47-1 | C9H13NO3 |
|
N-[4-[(2-氨基-3-氯吡啶-4-基)氧基]-3-氟苯基]-4-乙氧基-1-(4-氟苯基)-2-氧代-1,2-二氢吡啶-3-甲酰胺 | BMS-777607 | 1025720-94-8 | C25H19ClF2N4O4 |
|
N-[4-(氨基磺酰基)苄基]乙酰胺 | N-(4-sulfamoylbenzyl)acetamide | 2015-14-7 | C9H12N2O3S |
|
N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸 | 2-[4-(1,2,4-oxadiazol-5-one-3-yl)-phenylamino]-acetic acid | 872728-82-0 | C10H9N3O4 |
|
N-[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基兰索拉唑硫醚 | 1-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]thio]-1H-benzimidazole | 1083100-27-9 | C25H22F6N4O2S |
|
N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]氨基甲酸苄酯 | 3-fluoro-4-(6-(2-methyl-2H-tetrazole-5-yl)pyridin-3-yl)phenyl-carbamic acid benzylester | 1220910-89-3 | C21H17FN6O2 |
|
N-[3-氟-4-[(甲基氨基)羰基]苯基]-2-甲基丙氨酸 | 2-(3-fluoro-4-methylcarbamoyl-phenylamino)-2-methyl-propionic acid | 1289942-66-0 | C12H15FN2O3 |
|
N-[3-氟-4-[(甲基氨基)羰基]苯基]-2-甲基-丙氨酸甲酯 | N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine methyl ester | 1332524-01-2 | C13H17FN2O3 |
|